A retrospective study presented at the American Society of Clinical Oncology 2025 annual meeting evaluated women with endometrial neuroendocrine tumors and found that adjuvant treatment with...
Researchers found that the combination of benmelstobart, chemotherapy, and anlotinib yields improved response and progression-free survival in patients with advanced or recurrent endometrial cancer,...
The results of a large retrospective analysis noted significant age-related differences in the germline landscape of endometrial cancer. This study was presented as a poster at the 2025 American Society of...
